Boehringer, Autifony in deal for potassium channel modulators

Autifony Therapeutics Ltd. (Stevenage, U.K.) granted Boehringer Ingelheim GmbH (Ingelheim, Germany) an exclusive option to acquire

Read the full 164 word article

User Sign In